Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | marketing@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36?Washington?Street, Wellesley?Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
OABK hydrochloride | C14H20ClN5O4 | 1984862-48-7 | Details |
Deferoxamine Mesylate;desferrioxamine B;Desferrioxamine B mesylate;DFOM | C26H52N6O11S | 138-14-7 | Details |
NVX-207 | C36H59NO6 | 745020-66-0 | Details |
NVR 3-778 | C18H16F4N2O4S | 1445790-55-5 | Details |
NVS-PAK1-1 | C23H25ClF3N5O | 1783816-74-9 | Details |
Obidoxime dichloride | C14H16Cl2N4O3 | 114-90-9 | Details |
O-Desmethyl gefitinib | C21H22ClFN4O3 | 847949-49-9 | Details |
DA-3003-1 | C15H16ClN3O3 | 383907-43-5 | Details |
OBA-09 | C10H8O5 | 856095-68-6 | Details |
Octaethylene glycol | C16H34O9 | 5117-19-1 | Details |
Octaethylene glycol monomethyl ether | C17H36O9 | 25990-96-9 | Details |
Infigratinib phosphate | C26H34Cl2N7O7P | 1310746-10-1 | Details |
NVP-2 | C27H37ClN6O2 | 1263373-43-8 | Details |
Paroxetine hydrochloride | C19H21ClFNO3 | 78246-49-8 | Details |
NTRC-824 | C25H26F3N3O6S | 1623002-61-8 | Details |
NU6140 | C23H30N6O2 | 444723-13-1 | Details |
Buparlisib Hydrochloride;NVP-BKM120 Hydrochloride;BKM120 Hydrochloride | C18H22ClF3N6O2 | 1312445-63-8 | Details |
Nuvenzepine | C19H20N4O2 | 96487-37-5 | Details |
Nucleocidin;NSC 521007;4'-Fluoro-5'-O-sulfamoyladenosine | C10H13FN6O6S | 24751-69-7 | Details |
NU6300 | C20H23N5O3S | 2070015-09-5 | Details |
Ochratoxin B | C20H19NO6 | 4825-86-9 | Details |
NSC-87877 | C19H13N3O7S2 | 56990-57-9 | Details |
NSC781406 | C29H27F2N5O5S2 | 1676893-24-5 | Details |
KL1333 | C14H12N2O2 | 1800405-30-4 | Details |
NS1652 | C15H11F3N2O3 | 1566-81-0 | Details |
NS3623 | C15H10BrF3N6O | 343630-41-1 | Details |
NS5806 | C16H8Br2F6N6O | 426834-69-7 | Details |
NSC-60339 | 70-09-7 | Details |
NRC-2694 | C24H26N4O3 | 936446-61-6 | Details |
NS-2028 | C9H5BrN2O3 | 204326-43-2 | Details |
NS13001 | C17H16ClN7 | 1063331-94-1 | Details |
Notch inhibitor 1 | C26H25F7N4O3 | 1584647-27-7 | Details |
NSC16168 | C17H15NO9S3 | 6837-93-0 | Details |
NSC23925 | C22H25ClN2O2 | 858474-14-3 | Details |
Meseclazone;W2395;NSC297623 | C11H10ClNO3 | 29053-27-8 | Details |
NSC745885 | C14H6N2O2S | 4219-52-7 | Details |
Glyoxalic acid;Formylformic acid;Oxalaldehydic acid;NSC 27785 | C2H2O3 | 298-12-4 | Details |
Glibenclamide | C23H28ClN3O5S | 10238-21-8 | Details |
Nosiheptide | C51H43N13O12S6 | 56377-79-8 | Details |
Norgestimate metabolite Norelgestromin | C21H29NO2 | 53016-31-2 | Details |
Norverapamil hydrochloride | C26H37ClN2O4 | 67812-42-4 | Details |
Nonaethylene glycol | C18H38O10 | 3386-18-3 | Details |
Nonaethylene glycol monomethyl ether | C19H40O10 | 6048-68-6 | Details |
Nonaethylene glycol monododecyl ether;Nonaoxyethylene monododecyl ether;Polidocanol | C30H62O10 | 3055-99-0 | Details |
NMS-P515 | C21H29N3O2 | 1262395-13-0 | Details |
NKY80 | C12H11N3O2 | 299442-43-6 | Details |
NKH477;Colforsin dapropate hydrochloride | C27H44ClNO8 | 138605-00-2 | Details |
NK-252 | C13H11N5O3 | 1414963-82-8 | Details |
Otamixaban;FXV673 | C25H26N4O4 | 193153-04-7 | Details |
OSMI-1 | C28H25N3O6S2 | 1681056-61-0 | Details |
Otenzepad | C24H31N5O2 | 102394-31-0 | Details |
OTX008 | C52H72N8O8 | 286936-40-1 | Details |
Oteseconazole | C23H16F7N5O2 | 1340593-59-0 | Details |
Strontium ranelate | C12H12N2O8SSr | 135459-87-9 | Details |
Oxadiazon | C15H18Cl2N2O3 | 19666-30-9 | Details |
Oxamflatin | C17H14N2O4S | 151720-43-3 | Details |
Omtriptolide | C24H28O9 | 195883-06-8 | Details |
Osanetant;SR142801 | C35H41Cl2N3O2 | 160492-56-8 | Details |
Osajin;NSC 21565;CID 95168 | C25H24O5 | 482-53-1 | Details |
Ornidazole diol;Ro 11-2616 | C7H11N3O4 | 62580-80-7 | Details |
Orvepitant maleate;GW823296 maleate | C35H39F7N4O6 | 579475-24-4 | Details |
ORIC-101 | C34H47NO2 | 2222344-98-9 | Details |
Org41841 | C19H22N4O2S2 | 301847-37-0 | Details |
OPSS-PEG8-COOH | C27H46N2O11S2 | 1334177-96-6 | Details |
Opiranserin | C21H34N2O5 | 1441000-45-8 | Details |
Org-12962 | C10H11ClF3N3 | 132834-56-1 | Details |
ONO4057;ONO-LB457 | C27H34O7 | 134578-96-4 | Details |
ONO-2952 | C22H20ClFN2O2 | 895169-20-7 | Details |
ONC206 | C23H22F2N4O | 1638178-87-6 | Details |
OP-3633 | C30H39NO2 | 2102494-14-2 | Details |
Ophiobolin A | C25H36O4 | 4611-05-6 | Details |
Opicapone | C15H10Cl2N4O6 | 923287-50-7 | Details |
ON-013100 | C19H22O7S | 865783-95-5 | Details |
Org-26576 | C11H12N2O2 | 1026791-61-6 | Details |
Ciprofloxacin | C17H18FN3O3 | 85721-33-1 | Details |
ONO-5334 | C21H34N4O4S | 868273-90-9 | Details |
Odevixibat;A4250 | C37H48N4O8S2 | 501692-44-0 | Details |
Ogerin | C17H17N5O | 1309198-71-7 | Details |
Odiparcil | C15H16O6S | 137215-12-4 | Details |
Omidenepag isopropyl | C26H28N6O4S | 1187451-19-9 | Details |
Omidenepag | C23H22N6O4S | 1187451-41-7 | Details |
Amlexanox | C16H14N2O4 | 68302-57-8 | Details |
N-Acetylneuraminic acid | C11H19NO9 | 131-48-6 | Details |
Oglemilast | C20H13Cl2F2N3O5S | 778576-62-8 | Details |
Oleandomycin | C35H61NO12 | 3922-90-5 | Details |
Ombrabulin;AC7700;AVE8062 | C21H26N2O6 | 181816-48-8 | Details |
Ombrabulin hydrochloride;AVE8062 (hydrochloride);AC7700 (hydrochloride) | C21H27ClN2O6 | 253426-24-3 | Details |
Omapatrilat;BMS-186716 | C19H24N2O4S2 | 167305-00-2 | Details |
Olutasidenib;FT-2102 | C18H15ClN4O2 | 1887014-12-1 | Details |
Olinciguat | C21H16F5N7O3 | 1628732-62-6 | Details |
Okadaic acid | C44H68O13 | 78111-17-8 | Details |
OGT 2115 | C24H16BrFN2O4 | 853929-59-6 | Details |
Oxamniquine | C14H21N3O3 | 21738-42-1 | Details |
Oxitropium Bromide | C19H26BrNO4 | 30286-75-0 | Details |
Oxyfenamate;Oxyphenamate;P 301 | C11H15NO3 | 50-19-1 | Details |
p-MPPI hydrochloride | C25H27IN4O2HCl | 220643-77-6 | Details |
P110δ-IN-1;PWT-143 | C31H40N8O3S | 1595129-71-7 | Details |
Lenalidomide;CC-5013 | C13H13N3O3 | 191732-72-6 | Details |
Oxyphenbutazone | C19H20N2O3 | 129-20-4 | Details |
P-1075 | C12H17N5 | 60559-98-0 | Details |
Product Total: Product Page: | ||||
59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 |